| Structure |
Chemical Name |
CAS |
MF |
 |
1,3-bis(4-isobutylphenyl)butan-1-one |
|
C24H32O |
 |
Edoxaban Impurity 40 |
2081883-52-3 |
C14H27N3O3 |
 |
tert-Butyl 2-((4S,6S)-6-(chloromethyl(02,2-1,3-dioxan-4-yl)acetate |
521974-00-5 |
C13H23ClO4 |
![1-Piperazineethanol,4-[(2-chlorophenyl)(3-chlorophenyl)methyl]-, hydrochloride (1:2)](/CAS/20180808/GIF/126517-38-2.gif) |
1-Piperazineethanol,4-[(2-chlorophenyl)(3-chlorophenyl)methyl]-, hydrochloride (1:2) |
126517-38-2 |
C19H24Cl4N2O |
![(1R,2R,4S)-2-[(tert-butoxycarbonyl)aMino]-4-[(diMethylaMino)carbonyl]cyclohexyl Methanesulfonate](/CAS/20150408/GIF/929693-31-2.gif) |
(1R,2R,4S)-2-[(tert-butoxycarbonyl)aMino]-4-[(diMethylaMino)carbonyl]cyclohexyl Methanesulfonate |
929693-31-2 |
C15H28N2O6S |
 |
Bisoprolol EP IMpurity B HeMifuMarate (Bisoprolol n-Propyl Derivative HeMifuMarate) |
1447715-44-7 |
C18H31NO4 |
 |
Ticagrelor Impurity 39 |
|
|
 |
(1R,2S,5aS,6aS,7aR,8aS,10aS) |
|
|
 |
Nifuratel impurity E |
|
|
 |
Ibubinib impurity |
|
|
 |
(R)-2-((6-(3-((3-(2-cyanobenzyl)-1-Methyl-2,6-dioxo-1,2,3,6-tetrahydropyriMidin-4-yl)aMino)piperidin-1-yl)-3-Methyl-2,4-dioxo-3,4-dihydropyriMidin-1(2H)-yl)Methyl)benzonitrile |
1268836-55-0 |
C31H30N8O4 |
 |
(S)-ethyl 3-((R)-5-oxopyrrolidine-2-carbonyl)thiazolidine-4-carboxylate(DD) |
|
|
 |
1-(((2R,4R)-4-((Benzyloxy)methyl)-2-(2,4-difluorophenyl)tetrahydrofuran-2-yl)methyl)-1H-1,2,4-triazole |
165115-83-3 |
C21H21F2N3O2 |
 |
Benzene,1-ethoxy-4-(phenylmethyl)- |
35672-52-7 |
C15H16O |
 |
Rosuvastatin EP impurity H |
1335110-44-5 |
C22H28FN3O6S |
 |
9α-BroMobudesonide |
313474-59-8 |
C25H33BrO6 |
![Carbamic acid, N-[(1S,2S,4S)-2-hydroxy-4-[[(2-methylpropoxy)carbonyl]amino]-5-phenyl-1-(phenylmethyl)pentyl]-, 5-thiazolylmethyl ester](/CAS/20200515/GIF/1010809-39-8.gif) |
Carbamic acid, N-[(1S,2S,4S)-2-hydroxy-4-[[(2-methylpropoxy)carbonyl]amino]-5-phenyl-1-(phenylmethyl)pentyl]-, 5-thiazolylmethyl ester |
1010809-39-8 |
C28H35N3O5S |
 |
Vortioxetine Impurity 1 |
1293489-71-0 |
C17H20N2S |
 |
Neratinib Impurity 4 |
1144516-18-6 |
C31H32ClN6O3+ |
 |
Atracurium Impurity 29 |
|
|
 |
ドコサン酸とプロパン-1,2,3-トリオールのモノエステル |
30233-64-8 |
C25H50O4 |
 |
(3R,4R,5S)-ethyl 4-acetamido-5-amino-3-isopropoxycyclohex-1-enecarboxylate |
1052063-36-1 |
C14H24N2O4 |
 |
AFTMPFJWAIDLME-QWHCGFSZSA-N |
1808087-53-7 |
C15H19N3O3S |
 |
tetrahydrofuran-3-yl 2-cyclopentyl-2-hydroxy-2-phenylacetate |
1404453-75-3 |
C17H22O4 |
 |
FEXOフェナジノン |
76811-98-8 |
C32H37NO4 |
 |
N-(2-methyl-5-nitrophenyl)-N-(4-(pyridin-3-yl)pyrimidin-2-yl)acetamide |
|
C18H15N5O3 |
 |
開環アゼトレオナム |
87500-74-1 |
C13H19N5O9S2 |
 |
2’’-Desethyl-2’’-vinyl Simvastatin |
1449248-72-9 |
C25H36O5 |
![N-[2-(methylthio)ethyl]-2-[(3,3,3-trifluoropropyl)thio]-Adenosine 5''-(hydrogen P-1H-imidazol-1-ylphosphonate)](/CAS/20210111/GIF/1054332-15-8.gif) |
N-[2-(methylthio)ethyl]-2-[(3,3,3-trifluoropropyl)thio]-Adenosine 5''-(hydrogen P-1H-imidazol-1-ylphosphonate) |
1054332-15-8 |
C19H25F3N7O6PS2 |
 |
(R)-8-(ベンジルオキシ)-5-(オキシラン-2-イル)キノリン-2(1H)-オン |
173140-90-4 |
C18H15NO3 |
 |
Butylphthalide impurity |
16692-58-3 |
C12H14O2 |
![4-[6-(2-Chloroethyl)-3,6,7,8-tetrahydro-3-methylimidazo[4,5-h][1,4]benzothiazin-2-yl]butanoic acid](/CAS/20211123/GIF/2469039-29-8.gif) |
4-[6-(2-Chloroethyl)-3,6,7,8-tetrahydro-3-methylimidazo[4,5-h][1,4]benzothiazin-2-yl]butanoic acid |
2469039-29-8 |
C16H21Cl2N3O2S |
![(1R,3r,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 2-phenylacetate](/) |
(1R,3r,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 2-phenylacetate |
|
|
 |
Vonoprazan Impurity U3 |
|
|
 |
プレドニカルベート関連化合物A (1,2-DIHYDROPREDNI1,2-ジヒドロプレドニカルベート |
671225-26-6 |
C27H38O8 |
 |
Topiroxostat Impurity 41 |
|
|
 |
Palbociclib Impurity 59 |
1430196-98-7 |
C14H20N4O4 |
 |
Dapoxetine impurity 18 |
|
|
![methyl (41R,12S,13aS)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate](/CAS/20180808/GIF/18374-18-0.gif) |
methyl (41R,12S,13aS)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate |
18374-18-0 |
C21H26N2O3 |
![3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI)](/CAS/20150408/GIF/477600-76-3.gif) |
3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI) |
477600-76-3 |
C15H21N5O |
 |
Bisoprolol Impurity |
2226263-68-7 |
C18H31NO4 |
 |
Tenofovir Impurity 72 |
|
|
 |
Oxacillin Impurity 3 |
21106-64-9 |
C19H18ClN3O5S |
 |
Dapoxetine impurity 60 |
|
|
 |
Etoricoxib N'-Oxide |
325855-71-8 |
C18H15ClN2O3S |
 |
Vildagliptin Impurity 43 |
|
|
 |
5-クロロチオフェン-2-カルボン酸メチル |
35475-03-7 |
C6H5ClO2S |
 |
Cabozantinib impurity 23 |
406-00-8 |
C6H6FNO |
 |
(R)-2-フェニル-2-ピバルアミド酢酸 |
40610-41-1 |
C13H17NO3 |
 |
Milnacipran Impurity 11 |
1410831-12-7 |
C11H10O2 |
 |
Nicorandil Impurity 7 |
|
|
 |
Irsogladine Impurity GDT |
|
|
 |
Silodosin Impurity C |
|
|
 |
2-Oxazolidinone, 5-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-, (5S)- |
2514942-86-8 |
C13H15NO4 |
 |
1-benzyl-4-(piperidin-1-yl)-1,2,3,6-tetrahydropyridine |
53877-76-2 |
C17H24N2 |
 |
Didesmethyl Zolmitriptan |
139264-15-6 |
C14H17N3O2 |
 |
Fosinopril Sodium Impurity A (Fosinoprilat) |
|
|
 |
D-erythro-Hexonic acid, 6-S-2-benzothiazolyl-2,4-dideoxy-6-thio-, 1,1-dimethylethyl ester |
1469771-46-7 |
C17H23NO4S2 |
 |
Palbociclib Impurity 33 |
|
|
![1,4-ジヒドロ-2,6-ジメチル-4-(3-ニトロフェニル)-3,5-ピリジンジカルボン酸3-[2-[(3,3-ジフェニルプロピル)メチルアミノ]-1,1-ジメチルエチル]5-エチル](/CAS/20180703/GIF/210579-71-8.gif) |
1,4-ジヒドロ-2,6-ジメチル-4-(3-ニトロフェニル)-3,5-ピリジンジカルボン酸3-[2-[(3,3-ジフェニルプロピル)メチルアミノ]-1,1-ジメチルエチル]5-エチル |
210579-71-8 |
C37H44ClN3O6 |
 |
Milrinone IMpurity 1 |
|
|
 |
Dehydro Azelnidipine |
918659-10-6 |
C33H32N4O6 |
 |
Atorvastatin Cyclic Isopropyl Impurity |
873950-17-5 |
C33H35FN2O7 |
 |
2,2′-ビピリジン-6-オール |
101001-90-5 |
C10H8N2O |
 |
D,L-Venlafaxine-d10 Hydrochloride |
1216539-56-8 |
C17H28ClNO2 |
 |
Tetrahydro FuroseMide |
4793-38-8 |
C12H15ClN2O5S |
 |
(11β,16β)-9-BroMo-11-hydroxy-16-Methyl-17,21-bis(1-oxopropoxy)pregna-1,4-diene-3,20-dione |
52092-14-5 |
C28H37BrO7 |
 |
PraMipexole IMpurity V (PraMipexole IMpurity Z) |
|
|
 |
Mupirocin iMpurity 5 |
|
C26H44O9 |
 |
2H-3-Benzazepin-2-one, 3-(3-bromopropyl)-1,3,4,5-tetrahydro-7,8-dimethoxy- |
1192174-72-3 |
C15H20BrNO3 |
 |
D-erythro-Hexonic acid, 2,4-dideoxy-3,5-O-(1-methylethylidene)-, acetate (9CI) |
402508-35-4 |
C11H18O6 |
 |
sofosBuvir impurity 47 |
|
|
![(2S,5R)-2-carbamoyl-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl ethyl sulfate](/) |
(2S,5R)-2-carbamoyl-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl ethyl sulfate |
|
|
 |
Empagliflozin Impurity 57(R,R) |
|
|
 |
Rivaroxaban Degradation Impurity B |
|
|
 |
IPC-Mixed Tenofovir Trimer |
|
|
 |
Pregabalin Impurity 19 |
89015-27-0 |
C11H14O3 |
 |
Aprepitant Impurity 44 |
172676-88-9 |
C23H21F7N4O3 |
 |
N-(2-ベンゾイル-4-クロロフェニル)ホルムアミド |
10352-28-0 |
C14H10ClNO2 |
 |
Solifenacin impurity 17 |
1029430-94-1 |
C19H17N3O |
 |
Nifuratel Impurity |
167103-07-3 |
C6H5N3O4 |
 |
Cinacalcet Impurity 22 |
|
|
 |
Zanubrutinib Impurity |
3104323-56-7 |
|
 |
Olopatadine Impurity 8 |
|
|
![(1R,3S)-1-(1,3-ベンゾジオキソール-5-イル)-2,3,4,9-テトラヒドロ-1H-ピリド[3,4-B]インドール-3-カルボン酸メチルエステル](/CAS/GIF/171596-44-4.gif) |
(1R,3S)-1-(1,3-ベンゾジオキソール-5-イル)-2,3,4,9-テトラヒドロ-1H-ピリド[3,4-B]インドール-3-カルボン酸メチルエステル |
171596-44-4 |
C20H18N2O4 |
 |
octakis(6-chloro-6-deoxy)-γ-cyclodextrin |
173094-60-5 |
C48H72Cl8O32 |
![[4-[3-(イソプロピルアミノ)-2-ヒドロキシプロピルオキシ]フェニル]メタノール](/CAS/GIF/62572-93-4.gif) |
[4-[3-(イソプロピルアミノ)-2-ヒドロキシプロピルオキシ]フェニル]メタノール |
62572-93-4 |
C13H21NO3 |
 |
Amlodipine Impurity 16 |
|
C26H31ClN2O8S |
 |
AztreonaM IMpurity D |
|
|
 |
Lumateperone Impurity 5 |
|
|
 |
1-hydroxypropan-2-yl 2-(2-(4-((4-chlorophenyl)(phenyl)
methyl)piperazin-1-yl)ethoxy)acetate compound with 2-
hydroxypropyl 2-(2-(4-((4-chlorophenyl)(phenyl)methyl)
piperazin-1-yl)ethoxy)acetate (1:1) hydrochloride |
|
|
![7-(2-methoxypropanoyl)-5H-chromeno[2,3-b]pyridin-5-one](/) |
7-(2-methoxypropanoyl)-5H-chromeno[2,3-b]pyridin-5-one |
|
|
 |
Oxonic Acid Impurity 1 |
60301-55-5 |
C3H3N3O2 |
 |
Mirabegron Impurity 16 |
|
|
 |
2-Methyl-2-(4-vinylphenyl)propanoic acid |
1256584-72-1 |
C12H14O2 |
 |
Lercanidipine Impurity 4 |
2727061-30-3 |
C18H23NO2 |
![1,3-ビス[4-(2-メトキシエチル)フェノキシ]-2-プロパノール](/CAS/GIF/230975-30-1.gif) |
1,3-ビス[4-(2-メトキシエチル)フェノキシ]-2-プロパノール |
230975-30-1 |
C21H28O5 |
 |
2’-Deschloro-2’-hydroxy Dasatinib |
1159977-25-9 |
C22H27N7O3S |
 |
ペリンドプリルジケトピペラジン |
129970-98-5 |
C19H30N2O4 |
 |
Pitavastatin Impurity 35 |
|
|